- Home
- KXIN vs HOOK Comparison
KXIN vs HOOK Comparison
Compare KXIN & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- HOOK
- Stock Information
- Founded
- KXIN 2015
- HOOK 2011
- Country
- KXIN China
- HOOK United States
- Employees
- KXIN N/A
- HOOK N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- HOOK Health Care
- Exchange
- KXIN Nasdaq
- HOOK Nasdaq
- Market Cap
- KXIN 10.4M
- HOOK 11.9M
- IPO Year
- KXIN N/A
- HOOK 2019
- Fundamental
- Price
- KXIN $0.78
- HOOK $0.89
- Analyst Decision
- KXIN
- HOOK Hold
- Analyst Count
- KXIN 0
- HOOK 3
- Target Price
- KXIN N/A
- HOOK $4.50
- AVG Volume (30 Days)
- KXIN 144.3K
- HOOK 155.2K
- Earning Date
- KXIN 01-01-0001
- HOOK 08-11-2025
- Dividend Yield
- KXIN N/A
- HOOK N/A
- EPS Growth
- KXIN N/A
- HOOK N/A
- EPS
- KXIN N/A
- HOOK N/A
- Revenue
- KXIN N/A
- HOOK $9,351,000.00
- Revenue This Year
- KXIN N/A
- HOOK N/A
- Revenue Next Year
- KXIN N/A
- HOOK N/A
- P/E Ratio
- KXIN N/A
- HOOK N/A
- Revenue Growth
- KXIN N/A
- HOOK N/A
- 52 Week Low
- KXIN $0.64
- HOOK $0.72
- 52 Week High
- KXIN $29.54
- HOOK $6.00
- Technical
- Relative Strength Index (RSI)
- KXIN 36.20
- HOOK 19.78
- Support Level
- KXIN $0.81
- HOOK $0.89
- Resistance Level
- KXIN $0.85
- HOOK $0.95
- Average True Range (ATR)
- KXIN 0.06
- HOOK 0.06
- MACD
- KXIN -0.01
- HOOK -0.01
- Stochastic Oscillator
- KXIN 27.21
- HOOK 7.11
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.